Search results (577)
« Back to PublicationsRisk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B.
Journal article
Kalafateli M. et al, (2026), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 24, 701 - 712.e8
ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation.
Journal article
Tipton T. et al, (2026), Vaccine, 72
Response to Comments on 'Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines'.
Journal article
Campbell C. et al, (2026), Journal of viral hepatitis, 33
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies.
Journal article
Danysz M. et al, (2026), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 32, 41 - 55
Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross-Sectional Study.
Journal article
Drysdale M. et al, (2025), Journal of viral hepatitis, 32
HCV response-guided therapy: is shorter always better? - Authors' reply.
Journal article
Cooke GS. et al, (2025), Lancet (London, England), 406
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.
Journal article
Strain R. et al, (2025), Hepatology (Baltimore, Md.)
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity.
Journal article
Kronsteiner B. et al, (2025), Scientific reports, 15
Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines.
Journal article
Campbell C. et al, (2025), Journal of viral hepatitis, 32
Genome-wide association and gene-virus interaction study of liver disease in hepatitis C virus-infected patients
Preprint
Quistrebert J. et al, (2025)
Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design.
Journal article
Wang Z. et al, (2025), Cell reports, 44
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa.
Journal article
Downs LO. et al, (2025), The Journal of infection, 91
Human tonsil organoids reveal innate pathways modulating humoral and cellular responses to ChAdOx1.
Journal article
Pudjohartono MF. et al, (2025), PLoS pathogens, 21
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Journal article
Amini A. et al, (2025), Science immunology, 10
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
Journal article
Murray SM. et al, (2025), Science immunology, 10